ELL-22256-89708
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 917 / CA
- Registered
- 2021-09-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-09-15
Registered in v-safe
-
2021-09-15
Dose 1 — Pfizer-BioNTech
-
2021-09-15
Health check-in — day 0, dose 1Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-16
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-17
Survey response — days 1–6 daily, dose 1MedDRA: Brain fog — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Brain FogMedDRA releases: 2024-11 · check-in free text available
- 2021-09-18
- 2021-09-19
- 2021-09-20
- 2021-09-22
- 2021-09-29
-
2021-10-06
Dose 2 — Pfizer-BioNTech
-
2021-10-06
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Poor · Headache, NauseaFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — days 1–6 daily, dose 2MedDRA: Muscular weakness — Feeling: Fair · Site: Pain · Fever · Chills, HeadacheFree text: Weakness on neck muscleMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-09
- 2021-10-11
- 2021-10-15
- 2021-10-20
- 2021-10-29
- 2021-11-03
- 2021-11-12
- 2021-11-17
- 2022-01-05
-
2022-10-08
Survey response — 12 months, dose 2MedDRA: Dizziness, Headache, Menstruation irregular — Feeling: GoodFree text: Frequent Dizziness and headache, irregular periods.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-15 | Pfizer-BioNTech | No |
| 2 | 2021-10-06 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Brain Fog
Release 10 — day 0, dose 2
Systemic reaction (other): Dizziness
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Weakness on neck muscle
Release 12 — 12 months, dose 2
Symptoms: Frequent Dizziness and headache, irregular periods.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Muscular weakness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release